As efforts to contain artemisinin resistance and eliminate Plasmodium falciparum intensify, the accurate diagnosis and prompt effective treatment of malaria are increasingly needed in Myanmar and the Greater Mekong Sub-region (GMS). This study tested different incentives to increase RDT use and improve the quality of care among informal private healthcare providers in Myanmar.
Although the migrant workers are at high risk of malaria, there are many hidden challenges in universal coverage and utilization of the insecticide-treated nets (ITNs) in this populations, which this study seeks to document.
Emergence of artemisinin resistance in Southeast Asia poses a serious threat to the global control of Plasmodium falciparum malaria. Currently, artemisinin resistance extends across much of Myanmar. P falciparum parasites carrying K13-propeller mutations were recorded at high prevalence next to the northwestern border with India. Appropriate therapeutic regimens should be tested urgently and implemented comprehensively if spread of artemisinin resistance to other regions is to be avoided.
Author: Anderson TJC, Ashley EA, Cheah PY, Day NP, Dhorda M, Dondorp AM, Faiz MA, Flegg JA, Grist EPM, Guerin P, Hlaing T, Hlaing TM, Imwong M, Kyaw MP, Lin K, Lwin KM, Maude RJ, McDew-White M, Nair S, Nosten F, Plewes K, Pukrittayakamee S, Smithuis F, Tun KM, White NJ, Win AA, Woodrow CJ
Publication date: February 2015
Source: The Lancet Infectious Diseases